Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Nov;47(11):1339-1340.
doi: 10.1007/s00134-021-06510-2. Epub 2021 Sep 1.

COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges

Collaborators, Affiliations
Comment

COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges

Juergen Prattes et al. Intensive Care Med. 2021 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

JP has received personal fees from Gilead Sciences and Pfizer, research funding from MSD and is stoke holder of AbbVie Inc and Novo Nordisk. PK is supported by the German Federal Ministry of Research and Education and the State of North Rhine-Westphalia, Germany and has received non-financial scientific grants from Miltenyi Biotec GmbH, Bergisch Gladbach, Germany, and the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany, and received lecture honoraria from and/or is advisor to Akademie für Infektionsmedizin e.V., Ambu GmbH, Astellas Pharma, European Confederation of Medical Mycology, Gilead Sciences, GPR Academy Ruesselsheim, MSD Sharp & Dohme GmbH, Noxxon N.V., and University Hospital, LMU Munich outside the submitted work. MH received research funding from Gilead Sciences, Astellas, Scynexis, F2G and Pfizer.

Comment on

References

    1. Rouze A, Lemaitre E, Nseir S (2021) COVID-19-associated pulmonary invasive aspergillosis: high incidence or difficult diagnosis? Intensive Care Med. 10.1007/s00134-021-06499-8 - PMC - PubMed
    1. Prattes J, Wauters J, Giacobbe DR, Lagrou K, Hoenigl M, Group E-CS (2021) Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry. Intensive Care Med - PMC - PubMed
    1. Roman-Montes CM, Martinez-Gamboa A, Diaz-Lomeli P, Cervantes-Sanchez A, Rangel-Cordero A, Sifuentes-Osornio J, Ponce-de-Leon A, Gonzalez-Lara MF. Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis. Mycoses. 2021;64:364–371. doi: 10.1111/myc.13216. - DOI - PMC - PubMed
    1. Fekkar A, Neofytos D, Nguyen MH, Clancy CJ, Kontoyiannis DP, Lamoth F (2021) COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it? Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases - PMC - PubMed
    1. Prattes J, Wauters J, Giacobbe DR, Salmanton-Garcia J, Maertens J, Bourgeois M, Reynders M, Rutsaert L, van Regenmortel N, Lormans P, Feys S, Reisinger AC, Cornely OA, Lahmer T, Valerio M, Delhaes L, Jabeen K, Steinmann J, Chamula M, Bassetti M, Hatzl S, Richardson R, Lagrou K, Hoenigl M (2021) Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients– a multinational observational study by the European Confederation of Medical Mycology. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 10.1016/j.cmi.2021.08.014 - PMC - PubMed

MeSH terms